Developer docs
API playgroundTry for free, no card

Search company profiles

Athena Bioscience

Full company profile

uuid000dvzq

Namestring
Athena Bioscience
Legal namestring
Athena Bioscience, LLC
Company typeenum
Private
Founded yearstring
-
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAthens, United States
HQ citystring
Athens
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
specialty pharmaceuticals, hypertension treatment, extended-release tablets, cardiovascular drugs, branded pharmaceuticals
Industry1 code
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical Product Sales
TypeOne Time License
Description

Athena Bioscience generates revenue through the sale of specialty pharmaceutical products including Nexiclon XR (clonidine extended-release tablets for hypertension), QDOLO, and FIBRICOR. The company operates as a specialty pharma focused on optimizing proven pharmaceutical therapies.

athenabioscience.com
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Marketing or Sales, Operations, Personnel, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Athena Bioscience is a specialty pharmaceutical company that develops, markets, and distributes branded prescription medications focused on optimizing proven pharmaceutical therapies. Its lead product, Nexiclon XR, is a once-daily clonidine extended-release tablet indicated for the treatment of hypertension. The company also markets additional branded pharmaceutical products including QDOLO and FIBRICOR.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Athena Bioscience is a specialty pharmaceutical company offering a focused portfolio of branded medications. The primary product is Nexiclon™ XR, a once-daily clonidine extended-release tablet for hypertension treatment. The company's cardiovascular product portfolio is promoted through Sabal Therapeutics. The company operates affiliated websites including QDOLO.com and FIBRICOR.com, though detailed product information for those brands is not publicly available. The company focuses on optimizing proven pharmaceutical therapies to address unmet medical needs.

Product and service3 records
1Nexiclon XR
CategoryAntihypertensive medication
Description

Once-daily clonidine extended-release tablet indicated for the treatment of hypertension, marketed to healthcare providers and pharmacies.

2QDOLO
CategorySpecialty pharmaceutical product
Description

Branded pharmaceutical product in Athena Bioscience's portfolio, distributed alongside its other specialty medications.

3FIBRICOR
CategorySpecialty pharmaceutical product
Description

Branded pharmaceutical product in Athena Bioscience's portfolio of marketed medications.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2022-02-22
Description

Sabal Therapeutics was engaged by Athena Bioscience to promote their cardiovascular product portfolio. This partnership was announced in February 2022 and covers the promotion of products including Nexiclon XR, representing a key channel distribution arrangement for cardiovascular medications.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Athena Bioscience

Specialty Pharmaceuticalsathenabioscience.com

Athena Bioscience firmographics

Firmographics
Name
Athena Bioscience
Legal name
Athena Bioscience, LLC
Website
https://athenabioscience.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Athena Bioscience industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAA
Primary Care & General Medicine Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Specialty pharmaceuticals
  • Hypertension treatment
  • Extended-release tablets
  • Cardiovascular drugs
  • Branded pharmaceuticals

Where Athena Bioscience is headquartered

Location

Headquarters

HQ city
Athens
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Athena Bioscience business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Marketing or Sales, Operations, Personnel, Others

Revenue model

  1. Pharmaceutical Product Sales: Athena Bioscience generates revenue through the sale of specialty pharmaceutical products including Nexiclon XR (clonidine extended-release tablets for hypertension), QDOLO, and FIBRICOR. The company operates as a specialty pharma focused on optimizing proven pharmaceutical therapies.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Athena Bioscience product offering

Product offering

Core offering

Athena Bioscience is a specialty pharmaceutical company that develops, markets, and distributes branded prescription medications focused on optimizing proven pharmaceutical therapies. Its lead product, Nexiclon XR, is a once-daily clonidine extended-release tablet indicated for the treatment of hypertension. The company also markets additional branded pharmaceutical products including QDOLO and FIBRICOR.

Product overview

Athena Bioscience is a specialty pharmaceutical company offering a focused portfolio of branded medications. The primary product is Nexiclon™ XR, a once-daily clonidine extended-release tablet for hypertension treatment. The company's cardiovascular product portfolio is promoted through Sabal Therapeutics. The company operates affiliated websites including QDOLO.com and FIBRICOR.com, though detailed product information for those brands is not publicly available. The company focuses on optimizing proven pharmaceutical therapies to address unmet medical needs.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nexiclon XR Once-daily clonidine extended-release tablet indicated for the treatment of hypertension, marketed to healthcare providers and pharmacies.
  • QDOLO Branded pharmaceutical product in Athena Bioscience's portfolio, distributed alongside its other specialty medications.
  • FIBRICOR Branded pharmaceutical product in Athena Bioscience's portfolio of marketed medications.

Companies that use Athena Bioscience

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Athena Bioscience technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Athena Bioscience partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Sabal TherapeuticscoreChannel Partner/ Reseller/ Distributor · 22 February 2022Sabal Therapeutics was engaged by Athena Bioscience to promote their cardiovascular product portfolio. This partnership was announced in February 2022 and covers the promotion of products including Nexiclon XR, representing a key channel distribution arrangement for cardiovascular medications.

Scale indicators1 record

Recent moves4 records

Expansion highlights4 records

Athena Bioscience competitors and assessment

Company assessment

Market position

Competitive moat3 records

Customer concentration

Athena Bioscience social profiles

Digital presence

Athena Bioscience financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Athena Bioscience leadership team

Management profile

Number of profiles

Profiles1 record

Athena Bioscience funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Athena Bioscience M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Athena Bioscience

What does Athena Bioscience do?

Athena Bioscience is a specialty pharmaceutical company that develops, markets, and distributes branded prescription medications focused on optimizing proven pharmaceutical therapies. Its lead product, Nexiclon XR, is a once-daily clonidine extended-release tablet indicated for the treatment of hypertension. The company also markets additional branded pharmaceutical products including QDOLO and FIBRICOR.

Is Athena Bioscience a public or private company?

Athena Bioscience is a private company. It is classified as unknown and is currently operating.

When was Athena Bioscience founded?

Athena Bioscience was founded in -1. It employs 1 to 10 people.

Where is Athena Bioscience based?

Athena Bioscience is headquartered in Athens, United States, in the North America region.

How does Athena Bioscience make money?

One revenue line is on record: pharmaceutical Product Sales.

Does Athena Bioscience have an API?

No public API is recorded for Athena Bioscience.

What industry is Athena Bioscience in?

Athena Bioscience's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIAAAA, Primary Care & General Medicine Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals